References

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

10.1073/pnas.1000087107 · 2011 · External reference

Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection

10.1128/iai.00319-08 · 2008 · External reference

Multiresistant Gram-negative infections: a global perspective

10.1097/qco.0b013e32833f0d3e · 2010 · External reference

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

10.7326/0003-4819-135-1-200107030-00012 · 2001 · External reference

Urologic diseases in America Project: analytical methods and principal findings

10.1097/01.ju.0000152365.43125.3b · 2005 · External reference

Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection

10.1128/aac.02176-12 · 2013 · External reference

Antibiotics for emerging pathogens

10.1126/science.1176667 · 2009 · External reference

Origins and virulence mechanisms of uropathogenic Escherichia coli

10.1016/j.yexmp.2008.03.007 · 2008 · External reference

Bacterial iron sources: from siderophores to hemophores

10.1146/annurev.micro.58.030603.123811 · 2004 · External reference

Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis

10.1021/jo400976f · 2013 · External reference

Structural engineering of a phage lysin that targets Gram-negative pathogens

10.1073/pnas.1203472109 · 2012 · External reference

Enterobactin-mediated delivery of beta-lactam antibiotics enhances antibacterial activity against pathogenic Escherichia coli

10.1021/ja503911p · 2014 · External reference

Siderophore-drug complexes: potential medicinal applications of the “Trojan horse” strategy

10.1016/j.tips.2014.06.007 · 2014 · External reference

Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae

10.1016/j.ijmm.2007.03.002 · 2007 · External reference

Treatment and prevention of urinary tract infection with orally active FimH inhibitors

10.1126/scitranslmed.3003021 · 2011 · External reference

Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection

10.1128/iai.00470-13 · 2013 · External reference

Development of a recombinant FimCH vaccine for urinary tract infections

10.1007/978-1-4419-8889-8_41 · 2003 · External reference

Targeting virulence: a new paradigm for antimicrobial therapy

10.1038/nchembio.2007.24 · 2007 · External reference

From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections

10.1007/s11934-013-0354-5 · 2013 · External reference

Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients

10.1093/cid/cis252 · 2012 · External reference

Community detection in graphs

10.1016/j.physrep.2009.11.002 · 2010 · External reference

Communities in networks

2009 · External reference

Finding large average submatrices in high dimensional data

10.1214/09-aoas239 · 2009 · External reference

Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis

10.1086/426450 · 2005 · External reference

The siderophore yersiniabactin binds copper to protect pathogens during infection

10.1038/nchembio.1020 · 2012 · External reference

Metal selectivity by the virulence-associated yersiniabactin metallophore system

10.1039/c4mt00341a · 2015 · External reference

Human urinary composition controls siderocalin’s antibacterial activity

10.1074/jbc.m115.645812 · 2015 · External reference

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli

10.1371/journal.ppat.1000305 · 2009 · External reference

Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine

10.1586/erv.12.36 · 2012 · External reference

Global fluoroquinolone resistance epidemiology and implictions for clinical use

10.1155/2012/976273 · 2012 · External reference

Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection

10.1128/jcm.02086-12 · 2012 · External reference

Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance

10.1128/jcm.01488-07 · 2008 · External reference

Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli

10.1093/jac/dki468 · 2006 · External reference

Virulence characteristics and phylogenetic background of ciprofloxacin resistant Escherichia coli in the urine samples from Korean women with acute uncomplicated cystitis

10.3346/jkms.2010.25.4.602 · 2010 · External reference

Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis

10.1128/aac.49.1.26-31.2005 · 2005 · External reference

Virulence characteristics of Escherichia coli strains causing acute cystitis in young adults in Iran

10.1016/j.jinf.2004.05.021 · 2005 · External reference

Temporal trends in antimicrobial resistance and virulence-associated traits within the Escherichia coli sequence type 131 clonal group and its H30 and H30-Rx subclones, 1968 to 2012

10.1128/aac.03679-14 · 2014 · External reference

Three-decade epidemiological analysis of Escherichia coli O15:K52:H1

10.1128/jcm.00230-09 · 2009 · External reference

Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia

10.1128/aac.06120-11 · 2012 · External reference

Molecular characterization of uropathogenic Escherichia coli: nalidixic acid and ciprofloxacin resistance, virulent factors and phylogenetic background

10.7860/jcdr/2013/6613.3744 · 2013 · External reference

Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis

10.1111/j.1469-0691.2007.01775.x · 2007 · External reference

Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli

10.1021/pr4009749 · 2014 · External reference

Library on a slide for bacterial comparative genomics

10.1186/1471-2180-4-12 · 2004 · External reference

Rapid and simple determination of the Escherichia coli phylogenetic group

10.1128/aem.66.10.4555-4558.2000 · 2000 · External reference

Unresolved reference

2006 · External reference

Unresolved reference

External reference

Statistical mechanics of community detection

10.1103/physreve.74.016110 · 2006 · External reference

Biclustering algorithms for biological data analysis: a survey

10.1109/tcbb.2004.2 · 2004 · External reference